• Alterar país/idioma

    Parece que você está em {} — Você está no site {}.

    Cancelar

    País e idioma selecionados

    Você está sendo redirecionado para o site {}. A disponibilidade de produtos e serviços varia de acordo com o país. Deseja continuar?

    Continuar
    Cancelar

Whether you need to boost image definition or add spectral detail, Revolution FrontierTM

will advance the clinical value of CT.

Explore new areas of care

Your patients get a CT because they need answers, quickly. But a challenge
with conventional CT today is that doctors see the anatomy, but may be
unable to characterize disease due to lack of fine detail or lack of tissue
composition such as calcium, iodine, blood or fat. This can often lead to
additional follow-up tests to make the diagnosis. As a result, CT needs to
evolve: from anatomy to function, from structure to chemical composition,
and from high sensitivity (detection) to high specificity (disease characterization).
 

Our RevolutionTM brand of CT systems is built from our passion to provide you
with extraordinary technologies that will allow you to reach the right
diagnosis, effortlessly. To push the boundaries of what you expect from your
CT, enabling you to see beyond anatomy and explore new areas of care.
 

Introducing Revolution Frontier. From Innovation to Outcomes... Everyday.

product-product-categories-computed-tomography-revolution frontier-1 (1).png

Outcomes

As a provider in a high-performing clinical environment, you constantly look for opportunities to adopt the latest in imaging technologies, like spectral imaging. However, you can't afford to adopt this technology if it has limited utility or doesn't fit into the processes you already have in place. We addressed this challenge with GSI Pro.
 

GSI is our proven spectral imaging application that uses the Gemstone detector and rapid kV switching to acquire dual energy samples from a single source. By rapidly switching between two different kV energies at a rate of up to 0.25ms with sub-millimeter Z-axis registration, its temporal registration is over 165 times faster than other dual energy technologies. And the advantage of its single source architecture is the ability to generate material decomposition images over the full 50 cm field of view.

We addressed and improved the GSI experience to seamlessly integrate with AW applications and to significantly reduce reconstruction times. It's a breakthrough in spectral CT technology that effortlessly processes gigabytes of data at a time, making the clinical benefits of GSI routinely accessible.
 

The clinical benefits of GSI Pro include up to a 50 percent improvement in beam-hardening artifact due to bone, metal and other high-contrast materials such as iodine. It also has the ability to deliver non-contrast-like images by subtracting detected iodine from an image. By incorporating the latest in iterative reconstruction technology, ASiR-VTM,1 enables dose neutrality, lower image noise and improved low contrast detectability for patients of any size.

product-product-categories-computed-tomography-revolution frontier-group_4.png

With over 300 publications on GSI, example findings* by the academic community include: liver lesion detection by 17% and kidney lesion characterization by 12%, reducing the need for unnecessary follow-upsa,b, reduce contrast by at least50%, benefitting patients with renal functionc,d,e and 6 times reduction in non-interpretable scans with GSI MARf,g. (see GSI Infographic)

*The example findings cited are limited to the referenced studies only and may not be broadly applicable to your clinical practice.

References
a. Marin, D., et. al. "Characterization of Small Focal Renal Lesions: Diagnostic Accuracy with Single-Phase Contrast-enhanced Dual-Energy CT with Material Attenuation Analysis Compared with Conventional Attenuation Measurements." Radiology. 284, no. 3 (2017).
b. Liu, Qi-Yu, et. al. "Application of gemstone spectral imaging for efficacy evaluation in hepatocellular carcinoma after transarterial chemoembolization." World Journal of Gastroenterology 22, no. 11 (2016): 3242.
c. White Paper of the Society of Computed Body Tomography and Magnetic Resonance on Dual-Energy CT, Part 2: Radiation Dose and Iodine Sensitivity; Part 3:Vascular, Cardiac, Pulmonary and Musculoskeletal Applications; Part 4: Abdominal and Pelvic Applications. J Comput Assist Tomogr (2016).
d. Dong, Jian, et al. "Low-contrast agent dose dual-energy CT monochromatic imaging in pulmonary angiography versus routine CT." J of computer assisted tomography 37, no. 4 (2013): 618-625.
e. Shuman, William P., et. al. "Prospective comparison of dual-energy CT aortography using 70% reduced iodine dose versus single-energy CT aortography using standard iodine dose in the same patient." Abdominal Radiology 42, no. 3 (2017): 759-765.
f. Reynoso, Exequiel, et. al. "Periprosthetic Artifact Reduction Using Virtual Monochromatic Imaging Derived From Gemstone Dual-Energy Computed Tomography and Dedicated Software." J Comput Assist Tomogr . 2016; 40 (4): 649-657.
g. Pessis, Eric, et. al. "Virtual Monochromatic Spectral Imaging with Fast Kilovoltage Switching: Reduction of Metal Artifacts at CT" RadioGraphics 2013; 33:573-583.

GSI Education Center

Video Gallery

Related Content

GSI infographic

Disclaimers

1. The use of ASiR-V may reduce CT patient dose depending on the clinical task, patient size, anatomical location and clinical practice. A consultation with a radiologist and a physicist should be made to determine the appropriate dose to obtain diagnostic image quality for the particular clinical task.
2. As demonstrated in a phantom using iodinated contrast and hydroxyapatite.

Menções Legais

  1. As informações contidas neste material são apresentadas de forma geral, embora se pretenda que não haja dados imprecisos, pode haver diferentes interpretações a esse respeito; Essas informações podem ser restritas em seu país. As configurações e recursos finais do produto podem ser diferentes daqueles mostrados na foto/vídeo;
  2. Os produtos e tecnologias mencionados neste material estão sujeitos à regulamentação do governo e podem não estar disponíveis em todas as localidades. Seu embarque e efetiva comercialização só poderão ocorrer após a aprovação do regulador. Os produtos e tecnologias podem estar com nome fantasia distinto do aprovado, sendo que sua comercialização ocorrerá sob o nome registrado. A GE HealthCare reserva-se o direito de fazer alterações nas especificações e recursos mostrados neste documento ou de descontinuar o produto descrito a qualquer momento, sem aviso ou obrigação. Entre em contato com seu representante GE HealthCare para obter as informações mais atualizadas.
  3. O cliente e/ou fornecedor de cuidados de saúde tem a responsabilidade exclusiva de utilizar o seu próprio julgamento médico e profissional independente na tomada de decisões clínicas, médicas ou financeiras. Nada neste material deve ser utilizado para diagnosticar ou tratar uma doença ou condição de saúde.

Entre em contato conosco

Obrigado

Recebemos sua solicitação com sucesso.

A equipe da GE HealthCare entrará em contato em breve.

Algo deu errado

Verificaremos e logo retornaremos.

JB00039BR August 2020